Kawin Technology(SH:688687) Ge Long Hui A P P·2026-02-27 15:51Core Viewpoint - Kaiyin Technology (688687.SH) reported a significant decline in net profit for the year 2025, primarily due to substantial asset impairment provisions related to the withdrawal of a drug registration application [1] Financial Performance - The company achieved total operating revenue of 1.321 billion yuan, representing a year-on-year increase of 7.35% [1] - The net profit attributable to the parent company was 29.6312 million yuan, reflecting a year-on-year decrease of 79.19% [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses was 22.7647 million yuan, down 83.38% year-on-year [1] Reasons for Performance Changes - The primary reason for the performance decline was the company's decision to fully provision for asset impairment related to the withdrawal of the drug registration application for Pegylated Interferon α-2 Injection (new hepatitis B indication) based on the latest review recommendations from the National Medical Products Administration [1]